Guide
WHO issues global guideline on the use of GLP-1 medicines in treating obesity
External resource. Not made or verified by Public Protocol.
WHO news release of 1 December 2025 on its guideline conditionally recommending GLP-1 medicines for long-term obesity treatment in adults, with concerns about access.
https://www.who.int/news/item/01-12-2025-who-issues-global-guideline-on-the-use-of-glp-1-medicines-in-treating-obesity
- Maintainer
- World Health Organization
- Licence, as stated at its source
- Not stated on the page opened
- Open or commercial
- Open
- Maturity
- EstablishedOur reading, 16 November 2026
- Safety
- S3medical
- Review
- Listed 16 November 2026by Public Protocol editors
- Checked
- 16 November 2026
- Next check due
- 16 May 2027
- Steward
- Public Protocol editors
Where it sits in the blueprint
- Domains
- Stages
Learn
- Elements it supports
- Context
Climate, setting, scale, cost and skill: not stated in this entry. Check the source against your own place and numbers.
Verification
No verification is recorded on Public Platform for this entry. Records are added when someone reads it for accuracy, reviews it with a stated qualification, builds it or measures it.
Record
- How it came in
Seed catalogue, 16 November 2026. Listed from Praecise open research. The source was opened and described on the date shown.
- Licence
Not stated on the page opened. Read at https://www.who.int/news/item/01-12-2025-who-issues-global-guideline-on-the-use-of-glp-1-medicines-in-treating-obesity. How licences are recorded
- Something wrong?